The U.S. Centers for Disease Control and Prevention is helping fund a study to test the effects of early hepatitis B vaccination in Guinea-Bissau, a country in West Africa, the agency said on Dec. 18.
The CDC is granting $1.6 million to the University of Southern Denmark, according to a funding notice.
It will fund a randomized, controlled trial that will feature more than 14,000 infants, some of whom will receive a hepatitis B vaccine at birth and some of whom will receive the recommended first dose, which in Guinea-Bissau is around 1 month of age, a spokesperson for the Department of Health and Human Services, the CDC’s parent agency, told The Epoch Times in an email….